# Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

> **NCT00701181** · PHASE2 · TERMINATED · sponsor: **Quark Pharmaceuticals** · enrollment: 184 (actual)

## Conditions studied

- Diabetic Retinopathy
- Diabetes Complications

## Interventions

- **PROCEDURE:** Laser Treatment
- **DRUG:** PF-04523655 high
- **DRUG:** PF-04523655 middle
- **DRUG:** PF-04523655 low

## Key facts

- **NCT ID:** NCT00701181
- **Lead sponsor:** Quark Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 184 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2012-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701181, "Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00701181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*